Janney Montgomery Scott LLC Grows Stake in Colgate-Palmolive (NYSE:CL)

Janney Montgomery Scott LLC boosted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 2.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 387,487 shares of the company's stock after buying an additional 8,293 shares during the quarter. Janney Montgomery Scott LLC's holdings in Colgate-Palmolive were worth $35,227,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the company. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the third quarter worth about $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth approximately $53,000. Prospera Private Wealth LLC purchased a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $64,000. True Wealth Design LLC increased its stake in shares of Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company's stock valued at $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC increased its stake in shares of Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company's stock valued at $79,000 after buying an additional 368 shares during the period. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Up 0.0 %

Colgate-Palmolive stock traded up $0.03 during mid-day trading on Friday, hitting $87.94. The company had a trading volume of 2,679,229 shares, compared to its average volume of 4,991,511. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock's 50 day moving average price is $91.93 and its two-hundred day moving average price is $97.51. Colgate-Palmolive has a 12 month low of $80.03 and a 12 month high of $109.30. The company has a market capitalization of $71.85 billion, a PE ratio of 25.18, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive's payout ratio is currently 57.31%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CL. Barclays reduced their target price on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a research note on Friday, January 17th. StockNews.com cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. UBS Group reduced their target price on Colgate-Palmolive from $112.00 to $104.00 and set a "buy" rating on the stock in a research note on Thursday, January 16th. TD Cowen reduced their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research note on Wednesday, January 8th. Finally, Piper Sandler reduced their target price on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $101.11.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.34% of the company's stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.